Patterns of cardiac dysfunction coinciding with exertional breathlessness in hypertrophic cardiomyopathy

Dejan Maras1, Robin Chung, Alison Duncan

  • 1Canterbury Christ Church University, Canterbury, UK.

Insights

Breathlessness in hypertrophic cardiomyopathy (HCM) is often due to left ventricular outflow tract (LVOT) obstruction or other cardiac dysfunctions. Identifying these specific causes is crucial for tailored patient management.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology

Background:

  • Breathlessness is a common symptom in hypertrophic cardiomyopathy (HCM).
  • Left ventricular outflow tract (LVOT) obstruction is a frequent cause, but other mechanisms may contribute, similar to dilated cardiomyopathy.

Purpose of the Study:

  • To assess cardiac function during symptomatic periods in unselected HCM patients.
  • To identify patterns of cardiac dysfunction associated with breathlessness in HCM.

Main Methods:

  • Doppler echocardiography was used in 37 HCM patients and 17 controls.
  • Studies were conducted at rest and during dobutamine stress testing.
  • Stress endpoints included symptoms, blood pressure drop, arrhythmia, or maximum dobutamine dose.

Main Results:

  • HCM patients showed preserved ejection fraction but increased LVOT velocity and reduced long axis amplitude at rest.
  • At peak stress, LVOT obstruction and mitral regurgitation developed in many patients.
  • A subgroup without LVOT obstruction exhibited prolonged ejection time, impaired systolic amplitude, and altered filling dynamics.

Conclusions:

  • Exertional breathlessness in HCM is linked to LVOT obstruction/mitral regurgitation in most patients.
  • A significant minority experience breathlessness due to restrictive physiology or dyssynchrony at high heart rates.
  • Distinct management strategies are needed based on the underlying mechanism of breathlessness.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
957
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
564